Seba Hassan Attia

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Induced Apoptosis

Pulmonary Fibrosis

Transforming Growth Factor

Mesenchymal Stem Cells

Top Venues

Naunyn-Schmiedeberg's archives of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Seba Hassan Attia, Sara F Saadawy, Samaa M El-Mahroky, Mahitab M Nageeb
Alleviation of pulmonary fibrosis by the dual PPAR agonist saroglitazar and breast milk mesenchymal stem cells via modulating TGFß/SMAD pathway. Naunyn-Schmiedeberg's archives of pharmacology (2024)
Seba Hassan Attia, Sara F Saadawy, Samaa M El-Mahroky, Mahitab M Nageeb
Alleviation of pulmonary fibrosis by the dual PPAR agonist saroglitazar and breast milk mesenchymal stem cells via modulating TGFß/SMAD pathway. Naunyn-Schmiedeberg's archives of pharmacology 397 (8) (2024)
Seba Hassan Attia, Sara F Saadawy, Samaa M El-Mahroky, Mahitab M Nageeb
Alleviation of pulmonary fibrosis by the dual PPAR agonist saroglitazar and breast milk mesenchymal stem cells via modulating TGFß/SMAD pathway. Naunyn-Schmiedeberg's archives of pharmacology 397 (8) (2024)
Seba Hassan Attia, Sara F Saadawy, Samaa M El-Mahroky, Mahitab M Nageeb
Alleviation of pulmonary fibrosis by the dual PPAR agonist saroglitazar and breast milk mesenchymal stem cells via modulating TGFß/SMAD pathway. Naunyn-Schmiedeberg's archives of pharmacology 397 (8) (2024)
Seba Hassan Attia, Sara F Saadawy, Samaa M El-Mahroky, Mahitab M Nageeb
Alleviation of pulmonary fibrosis by the dual PPAR agonist saroglitazar and breast milk mesenchymal stem cells via modulating TGFß/SMAD pathway. Naunyn-Schmiedeberg's archives of pharmacology 397 (8) (2024)